Toxicologic Pathology Forum: A Roadmap for Building State-of-the-Art Digital Image Data Resources for Toxicologic Pathology in the Pharmaceutical Industry
Toxicologic Pathology · 2022-12 · 50 (8) · 942-949
DOI: 10.1177/01926233221132747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, online erschienen am 05.11.2022. Verfasst von Xing-Yue Ge und 14 weiteren Autor:innen. Beteiligte Einrichtung: Genentech Research and Early Development (gRED), Department of Development Sciences Informatics, Genentech Inc, South San Francisco, USA. Hauptthemen laut MEDLINE: Algorithms, Drug Industry. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Digitization of histologic slides brings with it the promise of enhanced toxicologic pathology practice through the increased application of computational methods. However, the development of these advanced methods requires access to substrate image data, that is, whole slide images (WSIs). Deep learning methods, in particular, rely on extensive training data to develop robust algorithms. As a result, pharmaceutical companies interested in leveraging computational methods in their digital pathology workflows must first invest in data infrastructure to enable data access for both data scientists and pathologists. The process of building robust image data resources is challenging and includes considerations of generation, curation, and storage of WSI files, and WSI access including via linked metadata. This opinion piece describes the collective experience of building resources for WSI data in the Roche group. We elaborate on the challenges encountered and solutions developed with the goal of providing examples of how to build a data resource for digital pathology analytics in the pharmaceutical industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Genentech Research and Early Development (gRED), Department of Development Sciences Informatics, Genentech Inc, South San Francisco, USA.
- Roche Pharma Research and Early Development (pRED), Pharmaceutical Sciences, Roche Innovation Center Basel, Switzerland.
- Roche Pharma Research and Early Development (pRED), Data & Analytics, Roche Innovation Center Basel, Switzerland.
- Genentech Research and Early Development (gRED), Department of Safety Assessment, Genentech Inc, South San Francisco, USA.
ORCID-Profile: Xing-Yue Ge, Juergen Funk, Fangyao Hu, Fernando Romero-Palomo, Vanessa Schumacher, Ruth Sullivan
Zitieren
APA
Ge, X. Y., Funk, J., Albrecht, T., Birkhimer, M., Gilsdorf, M., Hayes, M., Hu, F., Maliver, P., McCreary, M., Nguyen, T., Romero-Palomo, F., Seger, S., Fuji, R. N., Schumacher, V., & Sullivan, R. (2022). Toxicologic Pathology Forum: A Roadmap for Building State-of-the-Art Digital Image Data Resources for Toxicologic Pathology in the Pharmaceutical Industry. Toxicologic Pathology, 50(8), 942-949. https://doi.org/10.1177/01926233221132747
Vancouver
Ge XY, Funk J, Albrecht T, Birkhimer M, Gilsdorf M, Hayes M, et al. Toxicologic Pathology Forum: A Roadmap for Building State-of-the-Art Digital Image Data Resources for Toxicologic Pathology in the Pharmaceutical Industry. Toxicologic Pathology. 2022;50(8):942-949. doi:10.1177/01926233221132747
BibTeX
@article{Ge2022,
author = {Ge, Xing-Yue and Funk, Juergen and Albrecht, Tom and Birkhimer, Merima and Gilsdorf, Moritz and Hayes, Matthew and Hu, Fangyao and Maliver, Pierre and McCreary, Mark and Nguyen, Trung and Romero-Palomo, Fernando and Seger, Shanon and Fuji, Reina N and Schumacher, Vanessa and Sullivan, Ruth},
title = {Toxicologic Pathology Forum: A Roadmap for Building State-of-the-Art Digital Image Data Resources for Toxicologic Pathology in the Pharmaceutical Industry},
journal = {Toxicologic Pathology},
year = {2022},
volume = {50},
number = {8},
pages = {942--949},
doi = {10.1177/01926233221132747}
}
EUVIMED